Ancy Iruthayaraj

Novel antioxidant astaxanthin-s-allyl cysteine biconjugate diminished oxidative stress and mitochondrial dysfunction to triumph diabetes in rat model

Penislusshiyan Sakayanathan, Ancy Iruthayaraj, P. Kumaradhas et al. · Life Sciences · 2020 · 27 citations

Life Sciences, Biochemistry, Pharmacology +17

Biological interaction of newly synthesized astaxanthin-s-allyl cysteine biconjugate with Saccharomyces cerevisiae and mammalian α-glucosidase: In vitro kinetics and in silico docking analysis

Penislusshiyan Sakayanathan, Chitra Loganathan, Ancy Iruthayaraj et al. · International Journal of Biological Macromolecules · 2018 · 26 citations

Life Sciences, Biochemistry, Molecular Biology +11

S-allyl cysteine as potent anti-gout drug: Insight into the xanthine oxidase inhibition and anti-inflammatory activity

Preethi Johnson, Chitra Loganathan, Ancy Iruthayaraj et al. · Biochimie · 2018 · 25 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study

Ancy Iruthayaraj, Mugudeeswaran Sivanandam, P. Kumaradhas · Journal of Biomolecular Structure and Dynamics · 2020 · 25 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

S-allyl-glutathione, a synthetic analogue of glutathione protected liver against carbon tetrachloride toxicity: Focus towards anti-oxidative efficiency

Thayumanavan Palvannan, Chitra Loganathan, Ancy Iruthayaraj et al. · Environmental Toxicology and Pharmacology · 2017 · 14 citations

Pharmacy, Pharmacology, Toxicology +14